ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Structural and proliferative responses of the prostate to abrupt versus tapered discontinuation of dutasteride in short- and long-term treated rats.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess the structural response of the normal prostate during its recovery following dutasteride discontinuation, either abruptly or gradually, in short-term or long-term treated rats. Fifty-six adult male Wistar rats were randomly allocated into seven groups: a control group and two dutasteride-treated groups (for 4 or 8 weeks, 0.5 mg/kg/day, orally). Furthermore, each corresponding group of the 4- and 8-week groups was subjected to abrupt or tapered drug discontinuation. At the end, blood samples were withdrawn for testosterone (T) and dihydrotestosterone (DHT) analyses. Ventral prostates (VP) were resected and subjected to hematoxylin and eosin (H&E) and Masson trichrome (MTC) staining. Besides, polymerase chain reaction (PCR) analysis and immunohistochemical identification of proliferating cell nuclear antigen (PCNA), caspase-3, and androgen receptors (AR) were performed. After 4 and 8 weeks of treatment, VP showed acinar trophic changes with reduced epithelial thickness in H&E, increased Masson-stained collagen distribution area, suppression of proliferation marker PCNA, activation of apoptosis, and AR downregulation. Discontinuation of dutasteride, whether abruptly or gradually, after short-term treatment showed prostate re-expansion and proliferation in both designs of withdrawal. However, in long-term dutasteride-treated rats, tapered discontinuation maintained the attained atrophic changes provoked in the prostate versus abrupt discontinuation. Abrupt discontinuation was associated with enhanced AR expression coupled with prostate proliferation and caspase-3 downregulation, leading to marked prostate rebound. As a preclinical study, it was concluded that the duration of exposure and the discontinuation design, whether abrupt or tapered, were found to have an impact on the prostate's recovery following dutasteride cessation. Abrupt discontinuation was linked to structural prostate rebound, which may be explained by AR upregulation.
Indexed as
Identifiers
42825925What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.